{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:25:10Z","timestamp":1762507510404},"reference-count":15,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1001\/jamadermatol.2018.2681","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T16:15:08Z","timestamp":1536336908000},"page":"1312","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of Treatment of Refractory Granuloma Faciale With Intralesional Rituximab"],"prefix":"10.1001","volume":"154","author":[{"given":"Daniel","family":"Morgado-Carrasco","sequence":"first","affiliation":[{"name":"Department of Dermatology, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscila","family":"Giavedoni","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"Jos\u00e9 M.","family":"Mascar\u00f3","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Iranzo","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hospital Cl\u00ednic de Barcelona, Universitat de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6","key":"dbr180016r1","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.jaad.2005.08.021","article-title":"Granuloma faciale: a clinicopathologic study of 66 patients.","volume":"53","author":"Ortonne","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"dbr180016r2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/PAS.0b013e318271efd0","article-title":"Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing diseases.","volume":"37","author":"Cesinaro","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"dbr180016r3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2340\/00015555-2784","article-title":"Granuloma faciale treatment: a systematic review.","volume":"98","author":"Lindhaus","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"dbr180016r4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell\u2013directed therapy for inflammatory skin diseases.","volume":"129","author":"Nagel","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"11","key":"dbr180016r5","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/archderm.142.11.1407","article-title":"Successful use of rituximab for cutaneous vasculitis.","volume":"142","author":"Chung","year":"2006","journal-title":"Arch Dermatol"},{"key":"dbr180016r6","first-page":"19","article-title":"Diagnosis and treatment of IgG4-related disease.","volume":"401","author":"Kamisawa","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"dbr180016r7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/cup.1978.5.issue-2","article-title":"Immunofluorescence studies in granuloma eosinophilicum faciale.","volume":"5","author":"Nieboer","year":"1978","journal-title":"J Cutan Pathol"},{"issue":"7","key":"dbr180016r8","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/cup.2006.33.issue-7","article-title":"Direct immunofluorescence in granuloma faciale: a case report and review of literature.","volume":"33","author":"Barnadas","year":"2006","journal-title":"J Cutan Pathol"},{"issue":"2","key":"dbr180016r9","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaad.2003.11.071","article-title":"Granuloma faciale: a clinicopathological study of 11 cases.","volume":"51","author":"Marcoval","year":"2004","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"dbr180016r10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ajcp\/aqw004","article-title":"Granuloma faciale and erythema elevatum diutinum in relation to immunoglobulin g4-related disease: an appraisal of 32 cases.","volume":"145","author":"Kavand","year":"2016","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"dbr180016r11","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/art.v67.2","article-title":"The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients.","volume":"67","author":"Jachiet","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"dbr180016r12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s10067-017-3552-6","article-title":"Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.","volume":"36","author":"Colantuono","year":"2017","journal-title":"Clin Rheumatol"},{"issue":"6","key":"dbr180016r13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"dbr180016r14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000350559","article-title":"Rituximab therapy for severe cutaneous leukocytoclastic angiitis refractory to corticosteroids, cellcept and cyclophosphamide.","volume":"5","author":"El-Reshaid","year":"2013","journal-title":"Case Rep Dermatol"},{"issue":"3","key":"dbr180016r15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamadermatol.2016.4854","article-title":"IgG4-related disease with orbital pseudotumors treated with rituximab combined with palpebral surgery.","volume":"153","author":"Aouidad","year":"2017","journal-title":"JAMA Dermatol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2698663","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T16:10:59Z","timestamp":1542211859000},"score":1,"resource":{"primary":{"URL":"http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/jamadermatol.2018.2681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2018.2681","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}